Osaki, Shuhei
Tazawa, Hiroshi
Hasei, Joe
Yamakawa, Yasuaki
Omori, Toshinori
Sugiu, Kazuhisa
Komatsubara, Tadashi
Fujiwara, Tomohiro
Sasaki, Tsuyoshi
Kunisada, Toshiyuki
Yoshida, Aki
Urata, Yasuo
Kagawa, Shunsuke
Ozaki, Toshifumi
Fujiwara, Toshiyoshi
Article History
Received: 23 February 2016
Accepted: 13 June 2016
First Online: 30 June 2016
Competing interests
: Yasuo Urata is the president and CEO of Oncolys BioPharma, Inc., the manufacturer of OBP-301 (telomelysin). Hiroshi Tazawa and Toshiyoshi Fujiwara are consultants for Oncolys BioPharma, Inc.